http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1804464_PMID

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID346546376_AID1804464_PMID_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313074297_AID1804464_PMID_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313074310_AID1804464_PMID_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID346546366_AID1804464_PMID_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID346546361_AID1804464_PMID_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313074307_AID1804464_PMID_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103981238_AID1804464_PMID_VALUE1
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25103
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title Binding Assay from US Patent US10683295: \"Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof\"
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID313074307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID346546361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID313074310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID346546366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103981238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID313074297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID346546376
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1804464

Total number of triples: 19.